🔎 Trials Near Me

Dachaigh › Aillse a' bhroilleach › Texas › Austin

Sgrùdaidhean clionaigeach Aillse a' bhroilleach ann an Austin, TX

Tha 18 sgrùdaidhean airson Aillse a' bhroilleach a’ lorg phàirtichean aig làraichean ann agus timcheall air Austin (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

A’ fastadhÌre 3
  • Texas Oncology Central/South, Austin
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06982521

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

A’ fastadhÌre 1/2
  • New Experimental Therapeutics - NEXT Oncology, Austin
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT04585750

An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors

A’ fastadhÌre 1
  • Next Oncology Austin, Austin
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT07222267

A Phase 1/1b Study of IAM1363 in HER2 Cancers

A’ fastadhÌre 1
  • NEXT Oncology - Austin, Austin
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT06253871

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

A’ fastadhÌre 1/2
  • Texas Oncology, Austin
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT07287917

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

A’ fastadhÌre 1
  • NEXT Austin, Austin
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 26 Lùna 2026 · NCT07383506

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

A’ fastadhÌre 3
  • Texas Oncology - Austin, Austin
Aoisean 18 gu 100 · Gach gnè · Air ùrachadh 6 Lùna 2026 · NCT05232916

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

A’ fastadhÌre 1/2
  • Texas Oncology - Central / South Texas, Austin
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Lùna 2026 · NCT05579366

Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer

A’ fastadhÌre 1/2
  • Texas Oncology - Central/South, Austin
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Iuch 2026 · NCT07558733

Cancer Pain Management Using a Web-based Intervention

A’ fastadh
  • The University of Texas at Austin, Austin
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 9 Ògmh 2026 · NCT06085313

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

A’ fastadhÌre 3
  • Texas Oncology - Central South (Balcones Dr), Austin
  • Texas Oncology - Central South (James Casey), Austin
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Cèit 2026 · NCT07062965

Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors

A’ fastadhÌre 1
  • NEXT Oncology Austin, Austin
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Gibl 2026 · NCT07424547

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
  • Elligo Health Research, Inc., Austin
Aoisean 40 agus nas sine · Gach gnè · Air ùrachadh 20 Faoi 2026 · NCT05366881

Sample Collection for Ongoing Research and Product Evaluation Study

A’ fastadhSgrùdadh amharc
  • Natera, Inc., Austin
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Faoi 2026 · NCT07318051

A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors

A’ fastadhÌre 1
  • Exelixis Clinical Site #4, Austin
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Sult 2025 · NCT05932862

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

A’ fastadhSgrùdadh amharc
  • Texas Oncology - Austin, Austin
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Lùna 2025 · NCT03053193

A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer

A’ fastadhÌre 2
  • Texas Oncology PA (Austin), Austin
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 19 Ògmh 2025 · NCT06568692

Sgrùdaidhean Aillse a' bhroilleach ann am bailtean eile

Sgrùdaidhean eile ann an Austin

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.